Skip to main content
Toggle navigation
About us
Physiological Relevance
High Content Screening
Contact Us
Assay Development and Screening
Know-How
Cellular Models
MyoScreen™
OncoSpheres™
Cardiomyocytes
Hepatocytes
Renal Proximal Tubules
ReferenceCell™
HCS Facility
Workflow
Working Together
Cell-Based assays
Muscular Atrophy/Hypertrophy
OncoSpheres™ Drug Profiling
Micropattern Products
Chips
Standard Chips
Starter Chips
Motility Chips
Arena Chips
Custom Chips
Plates
Standard Plates
Starter Plates
Motility Plates
Custom Plates
Accessories
FAQ
Resource Center
Technology Overview
Publications
Enter your keywords
You are here
Home
About us
news
Award of Tremplin du Sénat
Award of Tremplin du Sénat
12 July 2008
Cytoo was rewarded at the Tremplin Entreprises of the French Senate in the Life Science category.
View official website
Follow us
Like us on Facebook
Find us on Twitter
Connect via Linkedin
Watch us on YouTube
Join us on SlideShare
Discover us on Scoop.it!
RSS
Latest news
CYTOO’s partner Astellas Gene Therapies to present results of an AGT/ CYTOO collaboration on clinical candidate selection to treat DMD at the 2nd Gene Therapy for Muscular Disorders Summit
05 April 2022
Grenoble, France, 5th April, 2022 CYTOO and Astellas Gene Therapies (
CYTOO and AskBio enter into research agreement to screen gene therapy candidates for rare muscle disorder
28 February 2020
Grenoble, France and Research Triangle Park, NC, 28 February, 2020
Axcella Enters into Collaboration with CYTOO to Explore Impact of Dysregulated Metabolism on Muscle Physiology
23 October 2019
Axcella Enters into Collaboration with CYTOO to Explore Impact of
CYTOO enters into Research and Option Agreement with Pfizer to develop a target discovery platform for Duchenne Muscular Dystrophy
06 September 2018
Grenoble, France and NEW YORK, 6 September, 2018 CYTOO and Pfizer